Harvard Bioscience, Inc. Announces Receipt Of Private Letter Ruling And Affirms Plan To Spin-Off Harvard Apparatus Regenerative Technology, Inc. Following Its Initial Public Offering
For investor inquiries, please call (508) 893-8066. Press releases may be found on our web site, http://www.harvardbioscience.com .
The Harvard Bioscience, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6426
CONTACT: Tom McNaughton CFO email@example.com Tel: 508 893-8999 Fax: 508 892-6135 David Green President firstname.lastname@example.org Chane Graziano CEO email@example.com
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts